DWM
ABCL icon

DKM Wealth Management’s AbCellera Biologics ABCL Stock Holding History

DKM Wealth Management’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$34.9K Hold
10,000
– – 0.03% 67
2025
Q4 		$34.2K Hold
10,000
– – 0.03% 69
2025
Q3 		$50.3K Hold
10,000
– – 0.04% 62
2025
Q2 		$34.3K Hold
10,000
– – 0.03% 56
2025
Q1 		$22.3K Hold
10,000
– – 0.02% 50
2024
Q4 		$29.3K Buy
+10,000
New +$27.8K 0.03% 52

Other funds holding ABCL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

DKM Wealth Management's ABCL Position: Q1 2026 in Review

DKM Wealth Management held its AbCellera Biologics (ABCL) position steady in Q1 2026 at 10,000 shares worth $34.9K. The position accounts for 0.03% of the portfolio, ranked #67.

DKM Wealth Management first reported a position in ABCL in Q4 2024 and has held it in 6 quarters since. The position peaked at $50.3K in Q3 2025. 138 funds tracked by Wall St. Rank hold ABCL as of Q1 2026.

  • DKM Wealth Management held 10,000 shares of AbCellera Biologics worth $34.9K as of Q1 2026.
  • DKM Wealth Management left its AbCellera Biologics share count unchanged in Q1 2026.
  • AbCellera Biologics made up 0.03% of DKM Wealth Management's portfolio in Q1 2026, its #67 holding.
  • DKM Wealth Management first reported a position in AbCellera Biologics in Q4 2024 and has held it in 6 quarters since.
  • DKM Wealth Management's AbCellera Biologics position peaked at $50.3K in Q3 2025.
  • 138 funds tracked by Wall St. Rank held AbCellera Biologics as of Q1 2026.

Based on DKM Wealth Management's 13F filing for Q1 2026, filed 10 Apr 2026.